SA Graan Maart 2018

34 / 116

Monsanto is ’n geregistreerde handelsnaam van Monsanto Technology LLC. Monsanto Suid-Afrika (Edms) Bpk, Posbus 69933, Bryanston, 2021.
Besoek ons verwysingshulpbronne
op sosiale media.
Tel: 011 790-8200
DIT IS HOE ONS ’N GROEIENDE
BEVOLKING GAAN VOED
20 jaar van produksie
op meer as 2,5 miljard
hektaar wêreldwyd
GEEN NADELIGE GEVOLGE
GEDOKUMENTEER
VOEDSELPRODUKSIEBEDREIGING VINNIGE BEVOLKINGSGROEI
ONS PROBLEEM
Klimaatsverandering
Beperkte en krimpende
hulpbronne
Plae
DIE OPLOSSING
GM-GEWASSE
Plantvariëteite wat die volgende bied:
• Groter oes
• Doeltreffender gebruik van hulpbronne
• Insekverdraagsaamheid
• Onkruiddoderverdraagsaamheid
• Groter biodiversiteit
• Verhoogde opbrengs
Beter saad help boere om meer te
produseer, terwyl hul minder gebruik
WAT KRY JY?
Voordele van GM-gewasse:
Verhoogde voedselsekerheid
Verminderde kweekhuisgasse
Afname in plaag- en
onkruiddodergebruik
GENOEG GESONDE VOEDSEL
Verhoogde volhoubaarheid
africa/2025/
Globaal in 2016 het 18 miljoen boere in
26 lande 185,1 miljoen hektaar
GM-gewasse geplant. (ISAAA.2016).
Sedert 1996 is die gebruik van
plaagdoders met 581.4 kg aktiewe
bestanddeel verminder en die
omgewingsimpak gemeet deur die
omgewingsimpak-kwosiënt (EIK-)aanwyser,
het met 18.5% gedaal. (Brookes & Barfoot)
Teen 2025 sal daar 4 MILJOEN
meer monde wees om te voed.
Dit is 7 MILJOEN meer as 2010.
3427 babas word elke dag gebore,
dit is 3 meer monde om te voed elke minuut.
A16861
FOCUS
Seed Special
Disclaimer
The views and opinions expressed in this article are purely a factual summary based on the authors’ extensive literature
review and personal experiences attending international conferences, specifically on this topic. Both authors share a
driven passion to share the knowledge gained on new breeding technologies and general innovation in applied molecu-
lar biology. The ARC is currently investigating the potential applications of these technologies but does not have any
active research projects using them yet.
Targeted breeding technologies
The EU recently had a workgroup looking
into the regulatory requirements of each
technology and it has made some recom-
mendations already.
South Africa is also proactive in this regard
with the Department of Science and Tech-
nology funding the Academy of Science of
South Africa’s (ASSAF) investigation into
these tools and their regulation. Their find-
ings and reviews from other countries’ cur-
rent regulations were last year published in
a report on new breeding technologies
(available from their webpage). They con-
cluded that these technologies could make
use of the current regulatory framework
of the GMO act, since the act ensures that
any transgene events would be adequate-
ly regulated as per SA law, while non-GM
events would exit from the process earlier.
South Africa, will however, most likely keep
in line with the regulations of their key trade
partners such as the EU, to ensure compli-
ance and continued trade.
What’s around the corner?
Targeted breeding technologies, like CRIS-
PR/Cas, are here to stay and will increas-
ingly play a bigger role in our daily lives. Not
only, helping with the development of new
high yielding cultivars or livestock with
superior characteristics and quality in far
shorter time, but also allow us to address
human disease at the molecular level.
In future, more medical treatments will rely
solely on the CRISPR/Cas technology to tar-
get cancers (leukaemia) and inheritable dis-
eases than the current limited cases in the
USA and UK. Indeed, an exciting time to be
a breeder and a potentially
brighter future for our pro-
ducers.